Correlation Between Mineralys Therapeutics, and Allovir
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Allovir, you can compare the effects of market volatilities on Mineralys Therapeutics, and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Allovir.
Diversification Opportunities for Mineralys Therapeutics, and Allovir
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Mineralys and Allovir is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Allovir go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Allovir
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.55 times more return on investment than Allovir. However, Mineralys Therapeutics, Common is 1.82 times less risky than Allovir. It trades about 0.04 of its potential returns per unit of risk. Allovir is currently generating about -0.03 per unit of risk. If you would invest 1,212 in Mineralys Therapeutics, Common on August 28, 2024 and sell it today you would earn a total of 58.00 from holding Mineralys Therapeutics, Common or generate 4.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Allovir
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Allovir |
Mineralys Therapeutics, and Allovir Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Allovir
The main advantage of trading using opposite Mineralys Therapeutics, and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Allovir vs. Anebulo Pharmaceuticals | Allovir vs. Mineralys Therapeutics, Common | Allovir vs. AN2 Therapeutics | Allovir vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |